編號
R8-003
徵稿主題
Prognosis Survival and Treatment Related Complications
題目
HR+/HER2− 轉移性乳癌中 CDK4/6 抑制劑的真實世界療效：Palbociclib 與 Ribociclib 的多中心比較研究
作者群
蘇柏旭1,
李春輝2,
楊展庚3,
Chang-Hsien Lu4,
Chien-Ting Liu5,
陳訓徹6,
黃若禕2,
鄭運聰7,
吳宗翰1
服務單位
1 Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Keelung
2 Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Keelung
3 Division of Medical Oncology, Department of Medicine, Chang Gung Memorial Hospital, Taoyuan
4 Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Chiayi
5 Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Kaohsiung
6 Division of Breast Surgery, Department of General Surgery, Chang Gung Memorial Hospital, Taoyuan
7 Division of Neurosurgery, Department of Surgery, Chang Gung Memorial Hospital, Keelung
